Assessing the Impact of New Technologies on Managing Chronic Respiratory Diseases.

Chronic respiratory diseases (CRDs), including asthma and chronic obstructive pulmonary disease (COPD), represent significant global health challenges, contributing to substantial morbidity and mortality. As the prevalence of CRDs continues to rise, particularly in low-income countries, there is a pressing need for more efficient and personalized approaches to diagnosis and treatment. This article explores the impact of emerging technologies, particularly artificial intelligence (AI), on the management of CRDs. AI applications, including machine learning (ML), deep learning (DL), and large language models (LLMs), are transforming the landscape of CRD care, enabling earlier diagnosis, personalized treatment, and enhanced remote patient monitoring. The integration of AI with telehealth and wearable technologies further supports proactive interventions and improved patient outcomes. However, challenges remain, including issues related to data quality, algorithmic bias, and ethical concerns such as patient privacy and AI transparency. This paper evaluates the effectiveness, accessibility, and ethical implications of AI-driven tools in CRD management, offering insights into their potential to shape the future of respiratory healthcare. The integration of AI and advanced technologies in managing CRDs like COPD and asthma holds substantial potential for enhancing early diagnosis, personalized treatment, and remote monitoring, though challenges remain regarding data quality, ethical considerations, and regulatory oversight.